cover of episode Memantine for the Prevention of Cognitive Dysfunction in Patients Receiving WBRT: First Report of RTOG 0614, a Placebo-controlled, Double-blind, Randomized Trial

Memantine for the Prevention of Cognitive Dysfunction in Patients Receiving WBRT: First Report of RTOG 0614, a Placebo-controlled, Double-blind, Randomized Trial

2012/12/27
logo of podcast ASTRO Journals

ASTRO Journals

Frequently requested episodes will be transcribed first

Shownotes Transcript

Anthony Zietman talks with author Nadia Laack about this game-changing research